The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016

JAMA. 2017 Dec 5;318(21):2137-2138. doi: 10.1001/jama.2017.14896.


This study uses the Drugs@FDA database to analyze clinical development times for drugs to treat serious diseases within the 4 FDA expedited programs intended to speed drug review and approval.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Approval / statistics & numerical data*
  • Time Factors
  • United States
  • United States Food and Drug Administration*